Lista de obras - Rossella Libé - Dominio Público Uruguay

18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease

scientific article published on 24 September 2018

18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

artículo científico publicado en 2009

A Feminizing Adrenocortical Carcinoma in the Context of a Late Onset 21-Hydroxylase Deficiency

artículo científico publicado en 2014

A primary adrenal non-Hodgkin's lymphoma presenting as an incidental adrenal mass

artículo científico publicado en 2006

A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutation

scientific article published on 20 October 2011

ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma

artículo científico publicado en 2009

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences

artículo científico publicado en 2015

ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome

artículo científico publicado en 2013

Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome

artículo científico publicado en 2010

Activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase

scientific article published on 01 April 2000

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment

artículo científico publicado en 2015

Adrenocortical carcinoma: a clinician's update

artículo científico publicado en 2011

Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy

artículo científico publicado en 2009

Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE

artículo científico publicado en 2012

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.

artículo científico publicado en 2017

Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome

artículo científico publicado en 2002

Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.

artículo científico publicado en 2005

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

article

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

artículo científico publicado en 2016

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma

artículo científico publicado en 2017

Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients

artículo científico publicado en 2004

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

artículo científico publicado en 2004

Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.

artículo científico publicado en 2004

Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment

artículo científico publicado en 2007

Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.

artículo científico publicado en 2012

Evaluation of serum prostate-specific antigen concentrations in women with Cushing's disease.

artículo científico publicado en 2003

Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype

artículo científico publicado en 2010

Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors

scientific article published on 23 June 2009

Genome-wide paternal uniparental disomy as a cause of Beckwith-Wiedemann syndrome associated with recurrent virilizing adrenocortical tumors

scientific article published on 03 November 2014

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas

scientific article published on 01 July 2007

Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours

artículo científico publicado en 2012

Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.

artículo científico publicado en 2012

Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.

artículo científico publicado en 2010

Integrated genomic characterization of adrenocortical carcinoma

artículo científico publicado en 2014

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

article

Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia

artículo científico publicado en 2013

Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors

artículo científico publicado en 2008

Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation

artículo científico publicado en 2014

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

artículo científico publicado en 2015

Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.

artículo científico publicado en 2014

Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease

scientific article published on 01 August 2001

Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

scientific article published on 16 November 2012

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

artículo científico publicado en 2005

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

artículo científico publicado en 2015

Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.

artículo científico publicado en 2005

No evidence for relevant QT interval prolongation in mitotane-treated patients with adrenocortical carcinoma

artículo científico publicado en 2012

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

artículo científico publicado en 2013

PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

artículo científico publicado en 2016

Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer.

artículo científico publicado en 2010

Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors

artículo científico publicado en 2008

Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors

artículo científico publicado en 2012

Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer

artículo científico publicado en 2010

Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma.

artículo científico publicado en 2015

Primary Aldosteronism and ARMC5 Variants

artículo científico publicado en 2015

Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings.

artículo científico publicado en 2014

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

artículo científico publicado en 2015

Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer

artículo científico publicado en 2014

Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.

artículo científico publicado en 2012

Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease

artículo científico publicado en 2005

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B-Secreting Adrenocortical Carcinoma.

artículo científico publicado en 2017

SDHA is a tumor suppressor gene causing paraganglioma

artículo científico publicado en 2010

SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

artículo científico publicado en 2015

SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

article

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.

artículo científico publicado en 2013

Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity

scientific article published on 01 February 2007

Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma

artículo científico publicado en 2016

Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion

artículo científico publicado en 2013

The Paradoxical Increase in Cortisol Secretion Induced by Dexamethasone in Primary Pigmented Nodular Adrenocortical Disease Involves a Glucocorticoid Receptor-Mediated Effect of Dexamethasone on Protein Kinase A Catalytic Subunits.

artículo científico publicado en 2009

The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits

artículo científico publicado en 2009

Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

artículo científico publicado en 2017

Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

artículo científico publicado en 2010

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

artículo científico publicado en 2011

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors

scientific article published on 22 July 2008

Wnt/β-Catenin Pathway Activation in Adrenocortical Adenomas Is Frequently due to Somatic CTNNB1-Activating Mutations, Which Are Associated with Larger and Nonsecreting Tumors: A Study in Cortisol-Secreting and -Nonsecreting Tumors.

artículo científico publicado en 2010

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

artículo científico publicado en 2010

[Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy]

scientific article published on 01 January 2008

[Adrenocortical carcinoma and pregnancy]

artículo científico publicado en 2016

[Adrenocortical carcinoma: Update in 2014]

artículo científico publicado en 2014

β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

artículo científico publicado en 2010

Lista de obras de Rossella Libé

18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease

18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.

A Feminizing Adrenocortical Carcinoma in the Context of a Late Onset 21-Hydroxylase Deficiency

A primary adrenal non-Hodgkin's lymphoma presenting as an incidental adrenal mass

A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutation

ACTH-independent Cushing's syndrome with bilateral micronodular adrenal hyperplasia and ectopic adrenocortical adenoma

ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences

ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome

Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome

Activities of 21-hydroxylase, 17alpha-hydroxylase and 17,20-lyase

Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment

Adrenocortical carcinoma: a clinician's update

Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy

Adrenocortical tumors: improving the practice of the Weiss system through virtual microscopy: a National Program of the French Network INCa-COMETE

Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.

Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome

Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.

Detection and monitoring of circulating tumor DNA in adrenocortical carcinoma

Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.

Endocrine tumors of the pancreas (EPTs) in multiple endocrine neoplasia (MEN1): up-date on prognostic factors, diagnostic procedures and treatment

Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.

Evaluation of serum prostate-specific antigen concentrations in women with Cushing's disease.

Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype

Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors

Genome-wide paternal uniparental disomy as a cause of Beckwith-Wiedemann syndrome associated with recurrent virilizing adrenocortical tumors

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas

Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours

Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.

Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers.

Integrated genomic characterization of adrenocortical carcinoma

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma

Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia

Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors

Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation

Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection.

Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.

Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease

Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas

Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.

No evidence for relevant QT interval prolongation in mitotane-treated patients with adrenocortical carcinoma

One-Year Progression-Free Survival of Therapy-Naive Patients With Malignant Pheochromocytoma and Paraganglioma

PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer.

Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors

Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors

Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer

Pregnancy in Women Previously Treated for an Adrenocortical Carcinoma.

Primary Aldosteronism and ARMC5 Variants

Primary pigmented nodular adrenocortical disease: the original 4 cases revisited after 30 years for follow-up, new investigations, and molecular genetic findings.

Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.

Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer

Rationale for anti-angiogenic therapy in pheochromocytoma and paraganglioma.

Retrovirus-like long-terminal repeat DQ-LTR13 and genetic susceptibility to type 1 diabetes and autoimmune Addison's disease

Reversal of a Blunted Follicle-Stimulating Hormone by Chemotherapy in an Inhibin B-Secreting Adrenocortical Carcinoma.

SDHA is a tumor suppressor gene causing paraganglioma

SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).

SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients.

Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity

Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma

Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion

The Paradoxical Increase in Cortisol Secretion Induced by Dexamethasone in Primary Pigmented Nodular Adrenocortical Disease Involves a Glucocorticoid Receptor-Mediated Effect of Dexamethasone on Protein Kinase A Catalytic Subunits.

The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits

Time Until Partial Response in Metastatic Adrenocortical Carcinoma Long-Term Survivors.

Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors

Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors

Wnt/β-Catenin Pathway Activation in Adrenocortical Adenomas Is Frequently due to Somatic CTNNB1-Activating Mutations, Which Are Associated with Larger and Nonsecreting Tumors: A Study in Cortisol-Secreting and -Nonsecreting Tumors.

Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors

[Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy]

[Adrenocortical carcinoma and pregnancy]

[Adrenocortical carcinoma: Update in 2014]

β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma